Clinical jobs increase as R&D and lab roles experience record growth
The post-Brexit landscape has witnessed an exponential boom in life science careers
Read More
Author: John Pinching
Novartis’ Kesimpta trial provides positive results for MS patients
MS patients given boost by results of study into Kesimpta – a self-administered treatment with potential to improve lives
Read More
Brain Training: BioMed X Institute collaborates with Boehringer Ingelheim
Sensor development project marks the fifth joint research effort between BioMed X with Boehringer Ingelheim
Read More
CHMP recommends Idorsia’s dual acting treatment Quviviq for insomnia patients
Quviviq can be used on a long-term basis, addressing a key limitation of existing therapies
Read More
Neglected rare disease patients offered hope in new plan
Unmet need among over 7000 rare diseases is being addressed in a comprehensive action plan
Read More- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
